Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Classificação em ações #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Preço da ação
$0.60736143
Valor de mercado
$58.28M
Variação (1 dia)
-1.04%
Variação (1 ano)
-21.09%
País
TW
Negociar Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Categoria

Histórico de preços das ações de Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Preço de fecho mais alto: $0.61 em 2026-08-01

Preço de fecho mais baixo: $1.47 em 2023-04-01
Histórico de preços das ações da Gwo Xi Stem Cell Applied Technology Co. , Ltd de 2023 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -11.38%
2025 1.08%
2024 -27.87%
2023 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$550.92 38.61%
US
$1.06K 59.05%
NL
$147.61 462.97%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH